Tenovin-6 significantly increased the Annexin V + CD133 + CD19− subpopulation from primary ALL cells (Figure 6E), suggesting that Tenovin-6 treatment eliminates ALL stem/progenitor cells. This evidence concerns the gene ANXA5 and acute lymphoblastic leukemia.